- Home
- FBLG vs PRPL Comparison
FBLG vs PRPL Comparison
Compare FBLG & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLG
- PRPL
- Stock Information
- Founded
- FBLG 2021
- PRPL 2010
- Country
- FBLG United States
- PRPL United States
- Employees
- FBLG N/A
- PRPL N/A
- Industry
- FBLG
- PRPL Home Furnishings
- Sector
- FBLG
- PRPL Consumer Discretionary
- Exchange
- FBLG NYSE
- PRPL Nasdaq
- Market Cap
- FBLG 37.1M
- PRPL 78.9M
- IPO Year
- FBLG 2024
- PRPL N/A
- Fundamental
- Price
- FBLG $0.63
- PRPL $0.70
- Analyst Decision
- FBLG Strong Buy
- PRPL Hold
- Analyst Count
- FBLG 4
- PRPL 2
- Target Price
- FBLG $13.00
- PRPL $1.25
- AVG Volume (30 Days)
- FBLG 539.5K
- PRPL 716.8K
- Earning Date
- FBLG 08-06-2025
- PRPL 08-04-2025
- Dividend Yield
- FBLG N/A
- PRPL N/A
- EPS Growth
- FBLG N/A
- PRPL N/A
- EPS
- FBLG N/A
- PRPL N/A
- Revenue
- FBLG N/A
- PRPL $472,015,000.00
- Revenue This Year
- FBLG N/A
- PRPL N/A
- Revenue Next Year
- FBLG N/A
- PRPL $10.65
- P/E Ratio
- FBLG N/A
- PRPL N/A
- Revenue Growth
- FBLG N/A
- PRPL N/A
- 52 Week Low
- FBLG $0.58
- PRPL $0.56
- 52 Week High
- FBLG $5.62
- PRPL $1.50
- Technical
- Relative Strength Index (RSI)
- FBLG 37.68
- PRPL 41.83
- Support Level
- FBLG $0.58
- PRPL $0.70
- Resistance Level
- FBLG $0.67
- PRPL $0.74
- Average True Range (ATR)
- FBLG 0.06
- PRPL 0.04
- MACD
- FBLG 0.00
- PRPL -0.00
- Stochastic Oscillator
- FBLG 24.11
- PRPL 0.50
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.